Targeting tumor-associated macrophages to synergize tumor immunotherapy

By Xiaonan Xiang, Jianguo Wang, D. Lu, Xiao Xu. Signal Transduction and Targeted Therapy, 2021

844 citations recorded by the source corpus.

The current treatment strategies in advanced malignancies remain limited. Notably, immunotherapies have raised hope for a successful control of these advanced diseases, but their therapeutic responses are suboptimal and vary considerably among individuals. Tumor-associated macrophages (TAMs) are a major component of the tumor microenvironment (TME) and are often correlated with poor prognosis and therapy resistance, including immunotherapies. Thus, a deeper understanding of the complex roles of TAMs in immunotherapy regulation could provide new insight into the TME. Furthermore, targeting of TAMs is an emerging field of interest due to the hope that these strategies will synergize with current immunotherapies. In this review, we summarize recent studies investigating the involvement of TAMs in immune checkpoint inhibition, tumor vaccines and adoptive cell transfer therapies, and discuss the therapeutic potential of targeting TAMs as an adjuvant therapy in tumor immunotherapies.

Subfields: Immunology, Oncology

View Paper: https://www.semanticscholar.org/paper/a464b7b71db95ff76520f61eceb31465a72fb2ee

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

  1. Vivek Panwar
  2. Aishwarya Singh
  3. Manini Bhatt
  4. Rajiv K. Tonk
  5. Shavkatjon Azizov
  6. A. Raza
  7. Shinjinee Sengupta
  8. QUAN LIU

Citations in the corpus